APA (7th ed.) Citation

A, R., L, B., X, W., T, D., Y, S., SC, P., . . . KC, A. (2025). Targeting Siglec-sialic acid checkpoint to reverse immune dysfunction mediated by plasmacytoid dendritic cells in myeloma. Blood advances, 9(19), 5085. https://doi.org/10.1182/bloodadvances.2025015980

Chicago Style (17th ed.) Citation

A, Ray, et al. "Targeting Siglec-sialic Acid Checkpoint to Reverse Immune Dysfunction Mediated by Plasmacytoid Dendritic Cells in Myeloma." Blood Advances 9, no. 19 (2025): 5085. https://doi.org/10.1182/bloodadvances.2025015980.

MLA (9th ed.) Citation

A, Ray, et al. "Targeting Siglec-sialic Acid Checkpoint to Reverse Immune Dysfunction Mediated by Plasmacytoid Dendritic Cells in Myeloma." Blood Advances, vol. 9, no. 19, 2025, p. 5085, https://doi.org/10.1182/bloodadvances.2025015980.